60 results
6-K
EX-10.1
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
of the Board comprised of two or more Directors, each of whom shall qualify as an Independent Director (as required by the rules of the Nasdaq Stock … to Ordinary Shares. The Administrator may award Dividend Equivalent Rights on an Award or independent of an Award. Dividend Equivalent Rights may
6-K
EX-10.3
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
directly or through others, solicit or attempt to solicit any employee, independent contractor or consultant of the Company Group or its affiliates … to terminate his relationship with the Company Group or its affiliates in order to become an employee, consultant or independent contractor
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
the Securities Act of 1933, as amended. The Board has determined that Dr. Quart is not an independent director in accordance with the listing requirements
6-K
EX-10.2
CNTB
Connect Biopharma Holdings Ltd
12 Jun 24
Current report (foreign)
4:47pm
employee, independent contractor or consultant of the Company Group or its affiliates to terminate his relationship with the Company Group or its … affiliates in order to become an employee, consultant or independent contractor to or for any other person or entity, or otherwise encourage or solicit any
6-K
41mzr
12 Feb 24
Current report (foreign)
4:50pm
6-K
EX-99.1
uzzyrb4n8q
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
xo44688qxetbubbskhdp
5 Jun 23
Current report (foreign)
4:28pm
S-8
EX-23.1
v59m 3h09r
1 Jul 22
Registration of securities for employees
5:12pm
F-3/A
y2e7pr0mkq sanw1j
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
EX-23.2
bdnct 92tj
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
6-K
EX-99.1
mkb xszavvd0utx7
10 Jun 22
Current report (foreign)
6:05am
F-3/A
EX-23.2
th41yti5sha2uz8m
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3/A
ryogdirg
20 May 22
Shelf registration (foreign) (amended)
6:54pm
6-K
EX-99.2
ea3t6mcsv 0n20r
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm